Cardiovascular disease Several GLP-1 RAs have demonstrated cardioprotective benefits, including reductions in MACE, heart failure hospitalizations, and progression of atherosclerosis
In molecular and clinical studies, Retatrutide pen 20 mg is described primarily through the lens of its tri-receptor mechanism of action
Mike Israetel : It's one of these things that just kind of accumulated for me
Sources include: Parker, C.H., Slattery, C., Brennan, D.J., & le Roux, C.W
However, these studies typically involved healthy volunteers or individuals with prediabetes rather than patients already receiving GLP-1 receptor agonist therapy, limiting direct applicability to the clinical question of combination benefits